3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
19
Lung Neoplasms
15
Multiple Myeloma
13
Leukemia, Myeloid, Acute
12
Glioma
10
Wilms Tumor
9
Lymphoma, Non-Hodgkin
9
Breast Neoplasms
9
Sarcoma
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Osteosarcoma
8
Neuroblastoma
8
Neoplasm Metastasis
8
Myelodysplastic Syndromes
8
Colorectal Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Carcinoma, Hepatocellular
8
Rhabdoid Tumor
7
Hepatoblastoma
7
Rhabdomyosarcoma
6
Ovarian Neoplasms
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Medulloblastoma
6
Lymphoma
6
Histiocytosis, Langerhans-Cell
6
Ependymoma
6
Sarcoma, Ewing
5
Rectal Neoplasms
5
Pancreatic Neoplasms
5
Leukemia, Myelomonocytic, Chronic
5
Interventions
Carboplatin
5
pembrolizumab
3
Paclitaxel
3
Observation
3
Capecitabine
3
Azacitidine
3
venetoclax
2
pertuzumab
2
olaparib
2
durvalumab
2
Tretinoin
2
Trastuzumab
2
Standard of Care
2
Oxaliplatin
2
Irinotecan
2
Immunotherapy
2
Chemoradiotherapy
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
toripalimab
1
tislelizumab
1
tegafur-gimeracil-oteracil
1
taxane
1
talazoparib
1
tagraxofusp
1
sarilumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
X-Rays
×
1 year
×
Clear all
No trials found.